Coexpression cluster:C1593
From FANTOM5_SSTAR
Full id: C1593_anaplastic_NK_blood_Natural_CD8_Whole_adult
Phase1 CAGE Peaks
Hg19::chr10:72357594..72357605,- | p4@PRF1 |
Hg19::chr10:72362487..72362507,- | p2@PRF1 |
Hg19::chr10:72362665..72362683,- | p5@PRF1 |
Hg19::chr19:51875523..51875549,- | p@chr19:51875523..51875549 - |
Hg19::chr19:55417469..55417480,+ | p2@NCR1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
2.28656823893637e-05 | 0.0144739769524672 | 2 | 137 | Natural killer cell mediated cytotoxicity (KEGG):04650 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0001906 | cell killing | 2.68685548807027e-05 |
GO:0006968 | cellular defense response | 0.000252485390717191 |
GO:0051801 | cytolysis of cells in other organism during symbiotic interaction | 0.000958744547581376 |
GO:0001907 | killing by symbiont of host cells | 0.000958744547581376 |
GO:0052331 | hemolysis by organism of red blood cells in other organism during symbiotic interaction | 0.000958744547581376 |
GO:0051817 | modification of morphology or physiology of other organism during symbiotic interaction | 0.000958744547581376 |
GO:0051715 | cytolysis of cells of another organism | 0.000958744547581376 |
GO:0052043 | modification by symbiont of host cellular component | 0.000958744547581376 |
GO:0006927 | transformed cell apoptosis | 0.000958744547581376 |
GO:0031640 | killing of cells of another organism | 0.000958744547581376 |
GO:0001897 | cytolysis by symbiont of host cells | 0.000958744547581376 |
GO:0052185 | modification of structure of other organism during symbiotic interaction | 0.000958744547581376 |
GO:0051818 | disruption of cells of other organism during symbiotic interaction | 0.000958744547581376 |
GO:0052332 | modification by organism of cell membrane in other organism during symbiotic interaction | 0.000958744547581376 |
GO:0051883 | killing of cells in other organism during symbiotic interaction | 0.000958744547581376 |
GO:0019836 | hemolysis by symbiont of host red blood cells | 0.000958744547581376 |
GO:0044003 | modification by symbiont of host morphology or physiology | 0.000958744547581376 |
GO:0052188 | modification of cellular component in other organism during symbiotic interaction | 0.000958744547581376 |
GO:0052111 | modification by symbiont of host structure | 0.000958744547581376 |
GO:0052025 | modification by symbiont of host cell membrane | 0.000958744547581376 |
GO:0044004 | disruption by symbiont of host cells | 0.000958744547581376 |
GO:0006926 | virus-infected cell apoptosis | 0.00122020237302143 |
GO:0006952 | defense response | 0.00146227471504837 |
GO:0042269 | regulation of natural killer cell mediated cytotoxicity | 0.00195732153961825 |
GO:0016514 | SWI/SNF complex | 0.00206483628486486 |
GO:0045471 | response to ethanol | 0.00206483628486486 |
GO:0001910 | regulation of leukocyte mediated cytotoxicity | 0.00230670741862533 |
GO:0031341 | regulation of cell killing | 0.00230670741862533 |
GO:0006915 | apoptosis | 0.00230670741862533 |
GO:0012501 | programmed cell death | 0.00230670741862533 |
GO:0042267 | natural killer cell mediated cytotoxicity | 0.00230670741862533 |
GO:0002228 | natural killer cell mediated immunity | 0.00230670741862533 |
GO:0016265 | death | 0.00239270756740181 |
GO:0008219 | cell death | 0.00239270756740181 |
GO:0009405 | pathogenesis | 0.00249236892117645 |
GO:0001909 | leukocyte mediated cytotoxicity | 0.00260949314776118 |
GO:0019835 | cytolysis | 0.00290159034559855 |
GO:0030101 | natural killer cell activation | 0.00317829321061253 |
GO:0051701 | interaction with host | 0.00378475306873572 |
GO:0048468 | cell development | 0.00380635062002154 |
GO:0007623 | circadian rhythm | 0.00474513809620455 |
GO:0044403 | symbiosis, encompassing mutualism through parasitism | 0.00499225835979043 |
GO:0044419 | interspecies interaction between organisms | 0.00499225835979043 |
GO:0016585 | chromatin remodeling complex | 0.00625013144668185 |
GO:0048869 | cellular developmental process | 0.00703128521102429 |
GO:0030154 | cell differentiation | 0.00703128521102429 |
GO:0010033 | response to organic substance | 0.00884539981063303 |
GO:0002449 | lymphocyte mediated immunity | 0.0100565938693465 |
GO:0002443 | leukocyte mediated immunity | 0.0106713602344203 |
GO:0002252 | immune effector process | 0.0147414128790072 |
GO:0045087 | innate immune response | 0.0149770229113583 |
GO:0046649 | lymphocyte activation | 0.0199598181369645 |
GO:0032502 | developmental process | 0.0208728226941865 |
GO:0005057 | receptor signaling protein activity | 0.0219067445981678 |
GO:0045321 | leukocyte activation | 0.0219067445981678 |
GO:0001775 | cell activation | 0.0245701659673497 |
GO:0006917 | induction of apoptosis | 0.0245701659673497 |
GO:0012502 | induction of programmed cell death | 0.0245701659673497 |
GO:0043065 | positive regulation of apoptosis | 0.0287498970203366 |
GO:0043068 | positive regulation of programmed cell death | 0.0287498970203366 |
GO:0051704 | multi-organism process | 0.0364586630602866 |
GO:0016023 | cytoplasmic membrane-bound vesicle | 0.0373049438326 |
GO:0031988 | membrane-bound vesicle | 0.0373049438326 |
GO:0031410 | cytoplasmic vesicle | 0.044289821495002 |
GO:0031982 | vesicle | 0.0443221006614301 |
GO:0044451 | nucleoplasm part | 0.0456578825829426 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
hematopoietic stem cell | 2.19e-31 | 172 |
angioblastic mesenchymal cell | 2.19e-31 | 172 |
hematopoietic cell | 5.33e-31 | 182 |
hematopoietic oligopotent progenitor cell | 4.39e-30 | 165 |
hematopoietic multipotent progenitor cell | 4.39e-30 | 165 |
leukocyte | 1.11e-24 | 140 |
nongranular leukocyte | 5.86e-21 | 119 |
hematopoietic lineage restricted progenitor cell | 7.71e-20 | 124 |
T cell | 1.95e-19 | 25 |
pro-T cell | 1.95e-19 | 25 |
lymphoid lineage restricted progenitor cell | 4.04e-18 | 52 |
lymphocyte | 1.83e-17 | 53 |
common lymphoid progenitor | 1.83e-17 | 53 |
mature alpha-beta T cell | 1.20e-15 | 18 |
alpha-beta T cell | 1.20e-15 | 18 |
immature T cell | 1.20e-15 | 18 |
mature T cell | 1.20e-15 | 18 |
immature alpha-beta T cell | 1.20e-15 | 18 |
myeloid cell | 1.75e-13 | 112 |
common myeloid progenitor | 1.75e-13 | 112 |
CD8-positive, alpha-beta T cell | 1.70e-11 | 11 |
myeloid leukocyte | 4.47e-08 | 76 |
CD14-positive, CD16-negative classical monocyte | 6.91e-08 | 42 |
classical monocyte | 8.87e-07 | 45 |
Ontology term | p-value | n |
---|---|---|
adult organism | 1.57e-28 | 115 |
blood | 3.01e-14 | 15 |
haemolymphatic fluid | 3.01e-14 | 15 |
organism substance | 3.01e-14 | 15 |
hematopoietic system | 1.17e-12 | 102 |
blood island | 1.17e-12 | 102 |
hemolymphoid system | 1.25e-11 | 112 |
Ontology term | p-value | n |
---|---|---|
leukemia | 7.93e-09 | 39 |
hematologic cancer | 1.46e-07 | 51 |
immune system cancer | 1.46e-07 | 51 |
myeloid leukemia | 5.86e-07 | 31 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
No analysis results for this cluster
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.